title: Responding to the evidence for improved treatment for cryptococcal meningitis in resource-limited settings.
authors.forename: Barbara
authors.initials: B
authors.lastname: Milani
authors.forename: Nathan
authors.initials: N
authors.lastname: Ford
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D017954:Africa South of the Sahara; D000666:Amphotericin B / Q000191:economics* / Q000600:supply & distribution; D000935:Antifungal Agents / Q000191:economics / Q000600:supply & distribution; D003906:Developing Countries; D015725:Fluconazole / Q000191:economics / Q000600:supply & distribution; D005437:Flucytosine / Q000191:economics* / Q000600:supply & distribution; D006801:Humans; D016919:Meningitis, Cryptococcal / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine